As the world is increasing its focus on sustainable food production and animal welfare, few companies embody the principles of innovation and responsibility quite like ECO Animal Health. With a global presence and a deep-rooted commitment to veterinary science, ECO stands at the forefront of advancing animal health—providing novel solutions that support farmers, veterinarians, and the wider agricultural industry. At its core, ECO is a company built on science, but guided by a mission: to improve the health and productivity of animals while addressing the challenges of a growing global population. Headquartered in the United Kingdom and operating in over 60 countries worldwide, ECO Animal Health has become a trusted name in the development, registration, and marketing of high-quality pharmaceutical products for livestock and poultry. The company’s strength lies in its unique ability to balance cutting-edge research with real-world agricultural needs—ensuring that products are not only effective but also economically viable for those who rely on them.

Founded in the early 1970s, ECO Animal Health initially focused on niche markets, building its reputation through strategic partnerships and regulatory expertise. Over the decades, the company has grown into a global force, best known for its flagship product Aivlosin®—a macrolide antibiotic used in the treatment of respiratory and enteric diseases in pigs and poultry. Aivlosin exemplifies ECO’s commitment to targeted therapies that reduce animal suffering, minimize treatment time, and support responsible use of antimicrobials.

Unlike traditional pharmaceutical companies, ECO Animal Health integrates innovation with agility. The company invests heavily in research and development, often working closely with universities, research centers, and veterinary professionals to stay ahead of disease trends and pathogen resistance. Its robust pipeline includes vaccines, nutritional health solutions, and new-generation antimicrobials aimed at enhancing animal well-being while aligning with global regulatory trends. ECO’s scientific work is matched by a sophisticated understanding of global markets. Navigating complex regulatory landscapes—from Europe and Asia to Latin America and North America—requires expertise and persistence. ECO’s regulatory and compliance teams play a vital role in bringing new products to market, ensuring that each formulation meets not just scientific benchmarks, but also the diverse legal frameworks and cultural nuances of different regions.

Beyond its pharmaceutical offerings, ECO Animal Health is deeply committed to stewardship—advocating for the responsible use of antibiotics and sustainable farming practices. The company promotes evidence-based veterinary practices and works closely with producers to develop treatment strategies that are both effective and environmentally responsible. In doing so, ECO supports the broader goal of preserving antibiotic efficacy while maintaining animal productivity. At the heart of ECO’s success is a strong and collaborative team that brings together scientists, veterinarians, agricultural specialists, and business professionals. The company culture emphasizes integrity, innovation, and a shared vision of making a tangible difference in animal health. This culture not only drives ECO’s operational success but also reinforces its reputation as a reliable and ethical partner in the veterinary space.

ECO Animal Health’s approach is particularly resonant in today’s agricultural environment, where producers are under increasing pressure to reduce antibiotic use, improve animal welfare, and ensure food safety—all while maintaining profitability. ECO helps its customers navigate this complex landscape through advanced therapies, technical support, and data-driven insights that foster more informed decision-making. As global concerns such as antimicrobial resistance (AMR), zoonotic diseases, and food security become more pressing, ECO’s role in the animal health value chain grows even more significant. The company continues to invest in vaccine technologies and alternative therapies, working to reduce dependence on antibiotics without compromising animal care. It is also exploring digital tools and diagnostics that can provide real-time health insights and improve disease management across farms.

In addition to its product-driven strategies, ECO Animal Health is mindful of its corporate social responsibility. The company supports initiatives that promote veterinary education, food safety awareness, and sustainable farming methods. It also actively participates in global conversations around One Health—a holistic approach that links the health of people, animals, and the environment. “At ECO Animal Health, we believe in smart, science-driven solutions that respect the balance between animal productivity, welfare, and public health. Our mission is not just to treat animals, but to support a more sustainable and resilient agricultural future.”

As the company looks to the future, ECO Animal Health is poised for further growth, driven by its strong product portfolio, expanding R&D capabilities, and a steadfast commitment to ethical innovation. Whether addressing respiratory diseases in swine or supporting poultry health with precision therapeutics, ECO continues to lead with purpose—proving that profitability and responsibility can, and must, go hand in hand. In a fast-changing world where agriculture meets science and sustainability, ECO Animal Health represents the best of both—offering the tools, insights, and integrity that the industry needs to thrive.